Ceftibuten Dihydrate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

1 Suppliers, 1 EU WC

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

7 Dossiers, 3 FDA Orange Book, 2 Europe, 2 Listed Dossiers

DRUG PRODUCT COMPOSITION

FOR SUSPENSION;ORAL - EQ 180MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - EQ 90MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 11 Roquette, 9 Sigachi Industries, 8 Gangwal Chemicals, 7 Microlex e.U, 6 BASF, 6 Seppic, 6 Gangwal Healthcare, 4 Actylis, 4 ACG Worldwide, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 DFE Pharma, 3 Lonza Capsugel, 3 Prachin Chemical, 3 Vasa Pharmachem, 3 Kerry, 2 Pharmatrans-Sanaq, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Nanjing Well Pharmaceutical, 1 SPI Pharma, 1 Pharm-RX Chemical, 1 Finar, 1 DKSH, 1 Ideal Cures Pvt Ltd, 1 Nanjing Bold Chemical, 1 Jai Radhe Sales, 1 Ingredion Pharma Solutions, 1 Qualicaps, 1 Pfanstiehl, 1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

19 Fillers, Diluents & Binders, 15 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 13 Direct Compression, 13 Lubricants & Glidants, 11 Solubilizers, 9 Coating Systems & Additives, 8 Empty Capsules, 8 Granulation, 7 Taste Masking, 7 Co-Processed Excipients, 6 Topical, 6 Parenteral, 5 Emulsifying Agents, 5 Controlled & Modified Release, 4 Film Formers & Plasticizers, 3 API Stability Enhancers, 2 Surfactant & Foaming Agents, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 1 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

Approved Drug Products containing Ceftibuten Dihydrate listed in the FDA Orange Book. Original Data : FDA Website

Ceftibuten Dihydrate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

1 Suppliers

1 EU WC

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

7 Dossiers

3 FDA Orange Book

2 Europe

2 Listed Dossiers

DRUG PRODUCT COMPOSITION

FOR SUSPENSION;ORAL - EQ 180MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION;ORAL - EQ 90MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

11 Roquette

9 Sigachi Industries

8 Gangwal Chemicals

7 Microlex e.U

6 BASF

6 Seppic

6 Gangwal Healthcare

4 Actylis

4 ACG Worldwide

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 DFE Pharma

3 Lonza Capsugel

3 Prachin Chemical

3 Vasa Pharmachem

3 Kerry

2 Pharmatrans-Sanaq

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Nanjing Well Pharmaceutical

1 SPI Pharma

1 Pharm-RX Chemical

1 Finar

1 DKSH

1 Ideal Cures Pvt Ltd

1 Nanjing Bold Chemical

1 Jai Radhe Sales

1 Ingredion Pharma Solutions

1 Qualicaps

1 Pfanstiehl

1 Rochem International Inc

EXCIPIENTS BY APPLICATIONS

19 Fillers, Diluents & Binders

15 Thickeners and Stabilizers

15 Disintegrants & Superdisintegrants

13 Direct Compression

13 Lubricants & Glidants

11 Solubilizers

9 Coating Systems & Additives

8 Empty Capsules

8 Granulation

7 Taste Masking

7 Co-Processed Excipients

6 Topical

6 Parenteral

5 Emulsifying Agents

5 Controlled & Modified Release

4 Film Formers & Plasticizers

3 API Stability Enhancers

2 Surfactant & Foaming Agents

2 Rheology Modifiers

2 Chewable & Orodispersible Aids

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

1 Finished Drug Prices

MARKET PLACE

2 APIs

Ceftibuten Dihydrate

SI PHARMS

FOR SUSPENSION;ORAL - EQ 180MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FOR SUSPENSION;ORAL - EQ 90MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

EQ 90MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

EQ 180MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons